No abstract available
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
CD2 Antigens / metabolism
-
CD3 Complex / metabolism
-
CD4 Antigens / metabolism
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Follow-Up Studies
-
Humans
-
Lymphoma, Large-Cell, Anaplastic / drug therapy
-
Lymphoma, Large-Cell, Anaplastic / metabolism
-
Lymphoma, Large-Cell, Anaplastic / pathology*
-
Lymphoma, T-Cell, Cutaneous / drug therapy
-
Lymphoma, T-Cell, Cutaneous / metabolism
-
Lymphoma, T-Cell, Cutaneous / pathology*
-
Male
-
Neoplasms, Second Primary / drug therapy
-
Neoplasms, Second Primary / metabolism
-
Neoplasms, Second Primary / pathology*
-
Poly(A)-Binding Proteins / metabolism
-
Prednisone / therapeutic use
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / metabolism
-
Skin Neoplasms / pathology*
-
T-Cell Intracellular Antigen-1
-
Vincristine / therapeutic use
Substances
-
CD2 Antigens
-
CD3 Complex
-
CD4 Antigens
-
Poly(A)-Binding Proteins
-
T-Cell Intracellular Antigen-1
-
TIA1 protein, human
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone